科学研究
学术论文
当前位置: 首页>>科学研究>>学术论文>>正文

    侯琳等Transformable Honeycomb-Like Nanoassemblies of Carbon Dots for Regulated Multisite Delivery and Enhanced Antitumor Chemoimmunotherapy

    2021-08-31 侯琳  点击:[]

    Transformable Honeycomb-Like Nanoassemblies of Carbon Dots for Regulated Multisite Delivery and Enhanced Antitumor Chemoimmunotherapy.

    【作者】Lin Hou, Dandan Chen, Ruiting Wang, Ruibing Wang, Huijuan Zhang, Zhenzhong Zhang, Zhihong Nie, Siyu Lu

    【期刊名】Angewandte Chemie International Edition

    【影响因子】2021: 15.336

    【作者单位】School of Pharmaceutical Sciences, Zhengzhou University, 100 Kexue Avenue, Zhengzhou 450001, PR China

    【年,卷():页码】2021, 133: 6655-6666

    【摘要】Tumor fibrotic stroma forms complex barriers for therapeutic nanomedicine. Although nanoparticle vehicles are promising in overcoming biological barriers for drug delivery, fibrosis causes hypoxia, immunosuppression and limited immunocytes infiltration, and thus reduces antitumor efficacy of nanosystems. Herein, we report the development of cancer-associated fibroblasts (CAFs) responsive honeycomb-like nanoassemblies of carbon dots (CDs) to spatially program the delivery of multiple therapeutics for enhanced antitumor chemoimmunotherapy. Doxorubicin (DOX) and immunotherapeutic enhancer (Fe ions) are immobilized on the surface of CDs, whereas tumor microenvironment modifier (losartan, LOS) is encapsulated within the mesopores. The drugs-loaded nanoassemblies disassociate into individual CDs to release LOS to mitigate stroma and hypoxia in response to CAFs. The individual CDs carrying DOX and Fe ion efficiently penetrate deep into tumor to trigger intensified immune responses. Our in vitro and in vivo studies show that the nanoassemblies exhibit effective T cells infiltration, tumor growth inhibition and lung metastasis prevention, thereby providing a therapeutic platform for desmoplasia solid tumor.

    【全文链接】https://onlinelibrary.wiley.com/doi/10.1002/anie.202014397


    上一条:侯琳等In situ triggering antitumor efficacy of alcohol-abuse drug disulfiram through Cu-based metal-organic framework nanoparticles
    下一条:赵孟阳等Which is Better for Nanomedicines: Nanocatalysts or Single-Atom Catalysts?

    关闭

版权所有:河南省肿瘤重大疾病靶向治疗与诊断重点实验室

地址:郑州市科学大道100号    邮编:450001